Huntington National Bank Merck & Co., Inc. Transaction History

Huntington National Bank

$12.7 Billion
Q2 2024

A detailed history of Huntington National Bank transactions in Merck & Co., Inc. stock. As of the latest transaction made, Huntington National Bank holds 318,429 shares of MRK stock, worth $36.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

318,429

Previous 317,674 0.24%

Holding current value

$36.2 Million

Previous $41.9 Million 5.95%

% of portfolio

0.31%

Previous 0.34%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$123.8 - $132.96 $93,469 - $100,384	755 Added 0.24%	318,429 $39.4 Million
Q1 2024 May 03, 2024	SELL	$113.24 - $131.95 $453,299 - $528,195	-4,003 Reduced 1.24%	317,674 $41.9 Million
Q4 2023 Feb 07, 2024	SELL	$100.18 - $109.02 $844,717 - $919,256	-8,432 Reduced 2.55%	321,677 $35.1 Million
Q3 2023 Nov 08, 2023	SELL	$102.95 - $114.33 $2.03 Million - $2.25 Million	-19,721 Reduced 5.64%	330,109 $34 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $1.73 Million - $1.89 Million	15,957 Added 4.78%	349,830 $40.4 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $95,528 - $106,590	-928 Reduced 0.28%	333,873 $35.5 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $100,381 - $128,702	-1,148 Reduced 0.34%	334,801 $37.1 Million
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $392,810 - $441,279	-4,647 Reduced 1.36%	335,949 $28.9 Million
Q2 2022 Aug 09, 2022	SELL	$83.49 - $94.64 $32,644 - $37,004	-391 Reduced 0.11%	340,596 $31.1 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $382,472 - $428,727	-5,203 Reduced 1.5%	340,987 $28 Million
Q4 2021 Jan 21, 2022	SELL	$72.28 - $90.54 $81,242 - $101,766	-1,124 Reduced 0.32%	346,190 $26.5 Million
Q3 2021 Oct 28, 2021	SELL	$71.68 - $78.83 $3.39 Million - $3.73 Million	-47,326 Reduced 11.99%	347,314 $26.1 Million
Q2 2021 Jul 30, 2021	BUY	$70.31 - $77.77 $5.18 Million - $5.73 Million	73,657 Added 22.95%	394,640 $30.7 Million
Q1 2021 Apr 12, 2021	SELL	$68.86 - $81.11 $670,902 - $790,254	-9,743 Reduced 2.95%	320,983 $24.7 Million
Q4 2020 Jan 11, 2021	SELL	$71.77 - $79.65 $1.05 Million - $1.17 Million	-14,659 Reduced 4.24%	330,726 $27.1 Million
Q3 2020 Oct 30, 2020	SELL	$73.18 - $82.95 $251,446 - $285,016	-3,436 Reduced 0.99%	345,385 $28.7 Million
Q2 2020 Jul 30, 2020	SELL	$70.42 - $80.13 $665,961 - $757,789	-9,457 Reduced 2.64%	348,821 $27 Million
Q1 2020 Apr 27, 2020	SELL	$63.36 - $87.82 $823,806 - $1.14 Million	-13,002 Reduced 3.5%	358,278 $27.6 Million
Q4 2019 Jan 17, 2020	SELL	$77.58 - $87.54 $168,115 - $189,699	-2,167 Reduced 0.58%	371,280 $33.8 Million
Q3 2019 Nov 01, 2019	SELL	$76.08 - $82.93 $793,818 - $865,291	-10,434 Reduced 2.72%	373,447 $31.4 Million
Q2 2019 Jul 23, 2019	SELL	$69.84 - $81.59 $348,571 - $407,215	-4,991 Reduced 1.28%	383,881 $32.2 Million
Q1 2019 Apr 09, 2019	SELL	$69.58 - $79.36 $1.12 Million - $1.28 Million	-16,148 Reduced 3.99%	388,872 $32.3 Million
Q4 2018 Jan 28, 2019	SELL	$65.24 - $75.71 $1.46 Million - $1.7 Million	-22,455 Reduced 5.25%	405,020 $30.9 Million
Q3 2018 Oct 18, 2018	SELL	$57.69 - $67.84 $1.66 Million - $1.96 Million	-28,821 Reduced 6.32%	427,475 $30.3 Million
Q2 2018 Jul 19, 2018	SELL	$50.83 - $59.72 $927,799 - $1.09 Million	-18,253 Reduced 3.85%	456,296 $27.7 Million
Q1 2018 Apr 30, 2018	SELL	$50.96 - $59.23 $1.25 Million - $1.45 Million	-24,546 Reduced 4.92%	474,549 $25.8 Million
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $1.02 Million - $1.22 Million	-19,735 Reduced 3.8%	499,095 $28.1 Million
Q3 2017 Oct 24, 2017	BUY	$58.67 - $63.13 $30.4 Million - $32.8 Million	518,830	518,830 $33.2 Million

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Merck & Co., Inc. Transaction History